We are reinventing the fundamental science underlying the development of new medicines and their use in individual patients.
Our philosophy:
|
Innovation
|
Converging technologies will bring medical breakthroughs. We integrate laboratory investigation, computer science, and clinical research to develop precision approaches for diagnosing and treating disease.
|
|
Open Sharing
|
Open data drives discovery. We are committed to accelerating research by making our methods, publications, software, and datasets freely available to the broader scientific community.
|
|
Training
|
We learn better together. Our team unites people with unique perspectives and expertise to cultivate the next generation of interdisciplinary leaders.
|
|
Translation
|
Patients’ needs guide our work. Partnering with clinicians, we aim to develop and deploy novel, clinic-ready solutions that improve patient care.
|
The LSP is a research and education program that is part of the Harvard Program in Therapeutic Science (HiTS). Our organization prepares students and fellows for leadership roles in academic research, industry, and government service.
Explore LSP Publications
Twitter @Harvard_Lab
First lab tweet! Sharing new papers:
PRINT Using Perturb-map, we show how ovarian tumors resist immunotherapy
PREPRINT Developed new technology to easily generate cell-targeted LNP-RNA @SantagataMDPhD @JoshuaBrodyMD @yizhoudonglab
Mark your calendars! The #NIHCommonFund is hosting a 2-day workshop on 3/11-3/12 to hear from the community about ideas to enable #PrecisionMedicine with #AI through the integration of #MedicalImaging with other #Data types. Register today! https://go.nih.gov/awiS2id
@ronny_drapkin @TanjinaKader @JiaRenLin YES! Excellent teamwork studying the development of fallopian tube precursors to high grade serous ovarian cancer.
Very proud of the impressive effort by @TanjinaKader, @JiaRenLin, Clemens Hug, and team. A total joy to work with them and colleagues.
And a delight to be able to…
Now in @CD_AACR: Multimodal Spatial Profiling Reveals Immune Suppression & Microenvironment Remodeling in Fallopian Tube Precursors to High-Grade Serous Ovarian Carcinoma - by @TanjinaKader, @JiaRenLin, Clemens Hug, @ronny_drapkin, @SantagataMDPhD, et al. https://doi.org/10.1158/2159-8290.CD-24-1366